A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects

Completed · Phase 3

Conditions studied: Acute Coronary Syndrome

In brief

This study will evaluate the relative efficacy and safety of prasugrel and clopidogrel in a medically managed Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) acute coronary syndrome (ACS) population (that is, patients who are not managed with acute coronary revascularization).

Key facts

Study ID
NCT00699998
Run by
Eli Lilly and Company
People needed
9326
Starts
2008-06-01
Expected to finish
2012-04-01
Last updated by the study team
2013-05-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.